Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok

Choose Your Language:

Willkommen Pr. Friedemann Paul!

Posted by: The Sumaira Foundation in News & Announcements

August 22, 2022 – The Sumaira Foundation is pleased to welcome Pr. Friedemann Paul of Charité – Universitätsmedizin Berlin (Germany) to join TSF’s medical advisory board.

Pr. Freidemann Paul

Pr. Friedemann Paul

Friedemann Paul is the group leader of the Clinical Neuroimmunology department of the NeuroCure Clinical Research Center at the Charité. He finished his medical education in Berlin and has been a board certified Neurologist since 2003. Friedemann Paul is a senior Neurologist in the Charité since 2004 until date. 

Since 2010, he has been leading the Neuroimmunology outpatients’ clinic in Buch, a suburb of Berlin. From 2011 to 2016 Paul was Professor (W2) of Neurology at the NeuroCure Clinical Research Center of Charité. In 2016 he joined as a tenured Professor (W2) of Clinical and Experimental Neuroimmunology at Charité. 

In 2018 he became a Scientific Director (acting) of the Experimental and Clinical Research Center (ECRC). His research focuses on Neuromyelitis optica (Devic’s Syndrome), Neurodegeneration and Neuroprotection in Multiple Sclerosis (MS), Experimental Autoimmune Encephalomyelitis (EAE), Neurological Complications of Chronic Inflammatory Bowel Diseases, Diagnostic Tools in Neuro‐immunology (Imaging (OCT, MRI, Ultrasound), Laboratory, and CSF Biomarkers) as well as the association of structural damage and dysfunction of the visual system in autoimmune disorders of the Central Nervous System. 

He has also been involved in a number of scientific activities including MS‐ Subcommittee of the European Neurological Society (ENS) (since 2008), Member, Editorial Board, EPMA Journal (since 2009), Associate Editor “Neurology: Neuroimmunology and Neuroinflammation” (since 2015) and Medical Consultant for EU‐ Announcements for Research Programmes on Rare Diseases (E‐RARE) (since 2016).   

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.